Literature DB >> 32621321

Spinal manipulation for the management of cervicogenic headache: A systematic review and meta-analysis.

Matthew Fernandez1,2, Craig Moore2,3, Jinghan Tan1, Derrick Lian1, Jeremy Nguyen1, Andrew Bacon1, Brie Christie1, Isabella Shen1, Thomas Waldie1, Danielle Simonet1, André Bussières4,5.   

Abstract

BACKGROUND: Spinal manipulative therapy (SMT) is frequently used to manage cervicogenic headache (CGHA). No meta-analysis has investigated the effectiveness of SMT exclusively for CGHA.
OBJECTIVE: To evaluate the effectiveness of SMT for CGHA. DATABASES AND DATA TREATMENT: Five databases identified randomized controlled trials comparing SMT with other manual therapies. The PEDro scale assessed the risk-of-bias. Pain and disability data were extracted and converted to a common scale. A random effects model was used for several follow-up periods. GRADE described the quality of evidence.
RESULTS: Seven trials were eligible. At short-term follow-up, there was a significant, small effect favouring SMT for pain intensity (mean difference [MD] -10.88 [95% CI, -17.94, -3.82]) and small effects for pain frequency (standardized mean difference [SMD] -0.35 [95% CI, -0.66, -0.04]). There was no effect for pain duration (SMD - 0.08 [95% CI, -0.47, 0.32]). There was a significant, small effect favouring SMT for disability (MD - 13.31 [95% CI, -18.07, -8.56]). At intermediate follow-up, there was no significant effects for pain intensity (MD - 9.77 [-24.21 to 4.68]) and a significant, small effect favouring SMT for pain frequency (SMD - 0.32 [-0.63 to - 0.00]). At long-term follow-up, there was no significant effects for pain intensity (MD - 0.76 [-5.89 to 4.37]) and for pain frequency (SMD - 0.37 [-0.84 to 0.10]).
CONCLUSION: For CGHA, SMT provides small, superior short-term benefits for pain intensity, frequency and disability, but not pain duration, however, high-quality evidence in this field is lacking. The long-term impact is not significant. SIGNIFICANCE: CGHA are a common headache disorder. SMT can be considered an effective treatment modality, with this review suggesting it providing superior, small, short-term effects for pain intensity, frequency and disability when compared with other manual therapies. These findings may help clinicians in practice better understand the treatment effects of SMT alone for CGHA.
© 2020 European Pain Federation - EFIC®.

Entities:  

Mesh:

Year:  2020        PMID: 32621321     DOI: 10.1002/ejp.1632

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  4 in total

1.  'Next steps' for researching orthopedic manual therapy.

Authors:  Chad E Cook; Megan Donaldson; Elaine Lonnemann
Journal:  J Man Manip Ther       Date:  2021-12

Review 2.  Expert panel's guideline on cervicogenic headache: The Chinese Association for the Study of Pain recommendation.

Authors:  Hong Xiao; Bao-Gan Peng; Ke Ma; Dong Huang; Xian-Guo Liu; Yan Lv; Qing Liu; Li-Juan Lu; Jin-Feng Liu; Yi-Mei Li; Tao Song; Wei Tao; Wen Shen; Xiao-Qiu Yang; Lin Wang; Xiao-Mei Zhang; Zhi-Gang Zhuang; Hui Liu; Yan-Qing Liu
Journal:  World J Clin Cases       Date:  2021-03-26       Impact factor: 1.337

3.  Effectiveness of Mulligan manual therapy over exercise on headache frequency, intensity and disability for patients with migraine, tension-type headache and cervicogenic headache - a protocol of a pragmatic randomized controlled trial.

Authors:  Kiran Satpute; Nilima Bedekar; Toby Hall
Journal:  BMC Musculoskelet Disord       Date:  2021-03-03       Impact factor: 2.362

4.  Exploring multidimensional characteristics in cervicogenic headache: Relations between pain processing, lifestyle, and psychosocial factors.

Authors:  Sarah Mingels; Wim Dankaerts; Ludo van Etten; Liesbeth Bruckers; Marita Granitzer
Journal:  Brain Behav       Date:  2021-09-02       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.